🔗 Share this article

The prestigious award in Physiology or Medicine was granted for transformative discoveries that clarify how the immune system attacks harmful pathogens while sparing the body's own cells.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this accolade.

The research identified specialized "sentinels" within the immune system that remove rogue defense cells capable of attacking the body.

The findings are now paving the way for innovative treatments for immune disorders and malignancies.

These winners will divide a monetary award valued at 11 million Swedish kronor.

Crucial Findings

"Their research has been essential for comprehending how the immune system functions and why we don't all suffer from serious autoimmune diseases," commented the chair of the award panel.

This trio's studies address a core question: In what way does the immune system defend us from countless infections while keeping our own tissues unharmed?

The immune system employs white blood cells that scan for indicators of disease, including viruses and bacteria it has never encountered.

Such defenders utilize sensors—called receptors—that are generated by chance in a vast number of variations.

This gives the defense network the ability to fight a wide array of invaders, but the randomness of the process unavoidably produces white blood cells that may attack the host.

Security Guards of the Body

Scientists earlier understood that a portion of these problematic white blood cells were destroyed in the thymus—the site where immune cells mature.

This year's Nobel Prize honors the discovery of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the system to neutralize other immune cells that assault the healthy cells.

It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel added, "The findings have established a novel area of research and accelerated the development of new treatments, for instance for cancer and autoimmune diseases."

Regarding cancer, regulatory T-cells block the system from fighting the tumor, so studies are focused on lowering their numbers.

For self-attack disorders, trials are exploring increasing T-reg cells so the body is not being harmed. A comparable approach could also be useful in reducing the chances of transplanted organ rejection.

Pioneering Experiments

Prof Shimon Sakaguchi, of Osaka University, performed tests on mice that had their immune gland removed, causing self-attack conditions.

The researcher demonstrated that introducing immune cells from other mice could prevent the illness—implying there was a mechanism for preventing defenders from attacking the body.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were investigating an inherited immune disorder in mice and humans that resulted in the identification of a gene vital for the way regulatory T-cells operate.

"The pioneering work has revealed how the body's defenses is controlled by T-reg cells, stopping it from accidentally targeting the healthy cells," said a leading physiology expert.

"This work is a remarkable illustration of how basic physiological study can have broad implications for public health."